AdvertisementFlawed Research Tool Leads To Faulty Medical FindingsSeptember 29, 2016Richard HarrisfacebookEmailA multi-million dollar effort to produce a test to guide treatment for a potentially lethal skin cancer recently fell apart after the scientific investigator discovered that the commercial antibodies he was using were unreliable. (Getty Images)
